Sarepta Therapeutics, Inc.
Nasdaq SRPT · Cambridge, MA
Works in Cardiovascular · Genetic & rare · Musculoskeletal · Neurology · Psychiatry · Respiratory
Sarepta Therapeutics, Inc. is a clinical trial sponsor based in Cambridge, MA, listed as Nasdaq SRPT. It has 13 active clinical trials with 2,009 planned participants, across 6 therapeutic areas. Since 2021 it has completed 11 trials and stopped 10 early.
Trial track record · since 2021
Financials · Nasdaq SRPT
Pipeline · 13 active trials
| Stage | Trial | Status |
|---|---|---|
On the market · 4 products
- AMONDYS 45 casimersen · NDA 213026 · prescription
- VYONDYS 53 golodirsen · NDA 211970 · prescription
- EXONDYS 51 eteplirsen · NDA 206488 · prescription
- ELEVIDYS delandistrogene moxeparvovec-rokl · BLA 125781 · prescription
Questions about Sarepta Therapeutics, Inc
Sarepta Therapeutics, Inc is lead sponsor of 13 active clinical trials on ClinicalTrials.gov, with 2,009 planned participants, in Cardiovascular, Genetic & rare, Musculoskeletal, Neurology and other areas. Since 2021 it has completed 11 trials and stopped 10 early.
Sarepta Therapeutics, Inc is based in Cambridge, MA and is listed as Nasdaq SRPT. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Sarepta Therapeutics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-06.
Products come from FDA's drug application database and, for vaccines, cell and gene therapies and blood products, FDA's Purple Book of licensed biologics; checked 2026-09-28.
Approve Suite is not affiliated with Sarepta Therapeutics, Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.